CD8A and neoplasm: Enhanced response to anti-PD-L1 immunotherapy, greater infiltration of CD8+ T-cells into the tumor, and normalization of MHC-I molecules on the cell surface were all results of this treatment, particularly when therapy was combined with IFN-γ [103].